市場調查報告書

腦膜炎疫苗的全球市場

Meningitis Vaccines Market

出版商 Research Nester 商品編碼 830896
出版日期 內容資訊 英文 312 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
腦膜炎疫苗的全球市場 Meningitis Vaccines Market
出版日期: 2019年04月01日內容資訊: 英文 312 Pages
簡介

本報告提供全球腦膜炎疫苗的市場相關分析,市場基本結構和最新形勢,主要的推動及阻礙市場要素,整體市場趨勢 (市場規模、成長率)的預測 (今後10年份),疫苗的各類型、各結構、各終端用戶及地區別詳細趨勢,主要企業簡介等調查。

第1章 簡介

第2章 前提條件、簡稱一覽

第3章 分析方法

第4章 摘要整理

第7章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場趨勢
  • 市場機會

第6章 風險分析

  • 需求風險
  • 供給風險

第7章 全球腦膜炎疫苗市場未來展望

  • 市場規模與其預測
    • 市場規模 (以金額為準,今後10年份)
      • 年度成長率 (以金額為準,今後10年份)
  • 市場佔有率與其預測 (以金額為準,今後10年份)
    • 各疫苗
      • 腦膜炎疫苗 (MenB,MenC,MenACWY)
      • 肺炎球菌疫苗 (PCV,PPV)
      • Hib疫苗
      • 市場向心力分析:各疫苗
      • 市場佔有率 (BPS) 分析:各疫苗
    • 各結構
      • 多糖體疫苗,結合型疫苗等
    • 各終端用戶
      • 醫院,診所,當天返回手術中心 (ASC) 等
    • 各地區
      • 北美,歐洲,亞太地區,南美,中東、非洲

第8章 北美的腦膜炎疫苗市場未來展望

  • 宏觀經濟指標
  • 市場規模與其預測 (以金額為準,總計9年份)
  • 市場佔有率與其預測 (以金額為準,總計9年份)
    • 各疫苗
    • 各結構
    • 各終端用戶
    • 各國 (美國,加拿大)

第9章 歐洲的腦膜炎疫苗市場未來展望

  • 宏觀經濟指標
  • 市場規模與其預測 (以金額為準,總計9年份)
  • 市場佔有率與其預測 (以金額為準,總計9年份)
    • 各國 (德國,英國,法國,義大利,西班牙,土耳其,俄羅斯等)

第10章 亞太地區的腦膜炎疫苗市場未來展望

  • 宏觀經濟指標
  • 市場規模與其預測 (以金額為準,總計9年份)
  • 市場佔有率與其預測 (以金額為準,總計9年份)
    • 各國 (印度,中國,日本,韓國,澳洲等)

第11章 南美的腦膜炎疫苗市場未來展望

  • 宏觀經濟指標
  • 市場規模與其預測 (以金額為準,總計9年份)
  • 市場佔有率與其預測 (以金額為準,總計9年份)
    • 各國 (北非各國,南非等)

第12章 中東、非洲的腦膜炎疫苗市場未來展望

  • 宏觀經濟指標
  • 市場規模與其預測 (以金額為準,總計9年份)
  • 市場佔有率與其預測 (以金額為準,總計9年份)
    • 各國 (美國,加拿大)

第13章 競爭環境

  • 主要企業的市場定位
  • 企業簡介
    • GlaxoSmithKline plc
      • 企業概要
      • 事業策略 (成長、擴大策略,流通管道策略,產品策略)
      • 主要產品
      • 財務成果
      • KPI (重要業績評估指標)
      • 風險分析
      • 近幾年趨勢
      • 各地區的存在感
      • SWOT分析
    • Pfizer Inc.
    • Sanofi Pasteur SA
    • Merck & Co., Inc.
    • Janssen
    • Panacea
    • Hualan Biological Engineering Inc.
    • Serum Institute of India Ltd.
目錄

Global market of meningitis vaccine stood at USD 12,783.1 Million in 2018 and is expected to reach USD 27,522.5 Million by the end of 2027, expanding at a CAGR of 8.9% over the forecast period i.e. 2019-2027. The advancements in meningitis vaccine and growing healthcare sector globally is anticipated to further boost the demand for meningitis vaccine in future.

Geographically, North America accounted for the largest market share of 41.2% in 2018 in the revenue of meningitis vaccine market globally. The market of North America region is expected to continue its dominance over the forecast period on the back of rising demand for efficient disease preventive Vaccine across the region.

Robust research and development are going on in healthcare sector to manufacture advanced and cost-effective meningitis Vaccine. The advanced meningitis vaccine further provides precise and accurate dosing with minimalist side effects to the vaccinated population.

The adoption of advanced and high end Vaccine is rising in developing regions such as India, China, Japan and others. To gain a competitive edge, different manufacturers of medical equipment have come up with various new Vaccine to effectively aid in the prevention of meningitis.

With USD 5,999.9 Million revenue by the end of 2027 in global market, Asia-Pacific Meningitis Vaccine market is expected to showcase lucrative growth over the forecast period. This growth is primarily attributed on the back of increasing governing regulatory body initiatives in order to reduce the number of deaths caused to meningitis across the region.

With the increasing focus of people on healthcare, the Asia-Pacific meningitis vaccine market is expected to witness rapid growth throughout the forecast period. Asia-Pacific market is expected to expand at a CAGR of 9.4% over the forecast period and expected to contribute a market share of 21.8% in global meningitis vaccine market.

Additionally, favorable government initiatives to develop the healthcare infrastructure coupled with increasing healthcare expenditure across the globe is envisioned to bolster the growth of the meningitis Vaccine market robustly over the forecast period.

Moreover, Europe is estimated to grow at a CAGR of 8.7% over the forecast period contributing a market share of 25.6% in the year 2027 in the global meningitis market.

Some of the leading manufacturers in this market are Sanofi Pasteur, GSK, Pfizer, Merck and Essilor among others.

1. Introduction

  • 1.1. Market Definition
  • 1.2. Product Overview
  • 1.3. Market Segmentation
  • 1.4. Features by Popular Products Available

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary- Global Meningitis Vaccine Market

5. Market Dynamics

  • 5.1. Drivers
  • 5.2. Restraints
  • 5.3. Trends
  • 5.4. Opportunities

6. Risk Analysis

  • 6.1. Demand Risk
  • 6.2. Supply Risk

7. Global Meningitis Vaccine Market Outlook

  • 7.1. Market Size and Forecast, 2018-2027
    • 7.1.1. By Value (USD Million)
      • 7.1.1.1. Y-o-Y Growth (%), 2019-2027
  • 7.2. Market Share and Forecast, 2018-2027
    • 7.2.1. By Vaccine
      • 7.2.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 7.2.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.1.2. Market Attractiveness Analysis, By Vaccine
      • 7.2.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 7.2.2. By Composition
      • 7.2.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 7.2.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.2.2. Market Attractiveness Analysis, By Composition
      • 7.2.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 7.2.3. By End User
      • 7.2.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 7.2.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.3.2. Market Attractiveness Analysis, By End User
      • 7.2.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 7.2.4. By Region
      • 7.2.4.1. Meningitis Vaccine Market Share (%), By Region (2018,2027F)
        • 7.2.4.1.1. North America
        • 7.2.4.1.2. Europe
        • 7.2.4.1.3. Asia Pacific
        • 7.2.4.1.4. Latin America
        • 7.2.4.1.5. Middle East and Africa

8. North America Meningitis Vaccine Market Outlook

8.1. Macro-Economic Indicators impacting the North America Meningitis Vaccine Market

  • 8.2. Market Size and Forecast, 2018-2027
    • 8.2.1. By Value (USD Million)
      • 8.2.1.1. Y-o-Y Growth (%), 2019-2027

8.3. Market Share and Forecast, 2018-2027

    • 8.3.1. By Vaccine
      • 8.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 8.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 8.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 8.3.2. By Composition
      • 8.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 8.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.2.2. Market Attractiveness Analysis, By Composition
      • 8.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 8.3.3. By End User
      • 8.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 8.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.3.2. Market Attractiveness Analysis, By End User
      • 8.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 8.3.4. By Country
      • 8.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 8.3.4.1.1. United States & Canada, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

9. Europe Meningitis Vaccine Market Outlook

  • 9.1. Macro-Economic Indicators impacting the Europe Meningitis Vaccine Market
  • 9.2. Market Size and Forecast, 2018-2027
    • 9.2.1. By Value (USD Million)
      • 9.2.1.1. Y-o-Y Growth (%), 2019-2027

9.3. Market Share and Forecast, 2018-2027

    • 9.3.1. By Vaccine
      • 9.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 9.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 9.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 9.3.2. By Composition
      • 9.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 9.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.2.2. Market Attractiveness Analysis, By Composition
      • 9.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 9.3.3. By End User
      • 9.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 9.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.3.2. Market Attractiveness Analysis, By End User
      • 9.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 9.3.4. By Country
      • 9.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 9.3.4.1.1. Germany, United Kingdom & France, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.4.1.2. Italy, Spain & Turkey, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.4.1.3. Russia & rest of Europe, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

10. Asia Pacific Meningitis Vaccine Market Outlook

  • 10.1. Macro-Economic Indicators impacting the Asia Pacific Meningitis Vaccine Market
  • 10.2. Market Size and Forecast, 2018-2027
    • 10.2.1. By Value (USD Million)
      • 10.2.1.1. Y-o-Y Growth (%), 2019-2027

10.3. Market Share and Forecast, 2018-2027

    • 10.3.1. By Vaccine
      • 10.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 10.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 10.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 10.3.2. By Composition
      • 10.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 10.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.2.2. Market Attractiveness Analysis, By Composition
      • 10.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 10.3.3. By End User
      • 10.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 10.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.3.2. Market Attractiveness Analysis, By End User
      • 10.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 10.3.4. By Country
      • 10.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 10.3.4.1.1. India, China and Japan, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.4.1.2. South Korea, Australia & Rest of Asia Pacific 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

11. Latin America Meningitis Vaccine Market Outlook

  • 11.1. Macro-Economic Indicators impacting the Latin America Meningitis Vaccine Market
  • 11.2. Market Size and Forecast, 2018-2027
    • 11.2.1. By Value (USD Million)
      • 11.2.1.1. Y-o-Y Growth (%), 2019-2027

11.3. Market Share and Forecast, 2018-2027

    • 11.3.1. By Vaccine
      • 11.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 11.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 11.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 11.3.2. By Composition
      • 11.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 11.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.2.2. Market Attractiveness Analysis, By Composition
      • 11.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 11.3.3. By End User
      • 11.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 11.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.3.2. Market Attractiveness Analysis, By End User
      • 11.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 11.3.4. By Country
      • 11.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 11.3.4.1.1. Brazil, Mexico & Rest of Latin America, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

12. Middle East and Africa Meningitis Vaccine Market Outlook

  • 12.1. Macro-Economic Indicators impacting the Middle East and Africa Meningitis Vaccine Market
  • 12.2. Market Size and Forecast, 2018-2027
    • 12.2.1. By Value (USD Million)
      • 12.2.1.1. Y-o-Y Growth (%), 2019-2027

12.3. Market Share and Forecast, 2018-2027

    • 12.3.1. By Vaccine
      • 12.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 12.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 12.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 12.3.2. By Composition
      • 12.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 12.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.2.2. Market Attractiveness Analysis, By Composition
      • 12.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 12.3.3. By End User
      • 12.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 12.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.3.2. Market Attractiveness Analysis, By End User
      • 12.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 12.3.4. By Country
      • 12.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 12.3.4.1.1. Middle East & Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.4.1.1.1. North Africa, South Africa & Rest of Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

13. Competitive Landscape

  • 13.1. Competitive Positioning of Major Players in Global Meningitis Vaccine Market
  • 13.2. Company Profiles
    • 13.2.1. GlaxoSmithKline plc
      • 13.2.1.1. Company Overview
      • 13.2.1.2. Business Strategy
        • 13.2.1.2.1. Growth Expansion Strategy
        • 13.2.1.2.2. Distribution Channel Strategy
        • 13.2.1.2.3. Product Strategy
      • 13.2.1.3. Key Product Offerings
      • 13.2.1.4. Financial Performance
      • 13.2.1.5. Key Performance Indicators
      • 13.2.1.6. Risk Analysis
      • 13.2.1.7. Recent Development
      • 13.2.1.8. Regional Presence
      • 13.2.1.9. SWOT Analysis
    • 13.2.2. Pfizer Inc.
    • 13.2.3. Sanofi Pasteur SA
    • 13.2.4. Merck & Co., Inc.
    • 13.2.5. Janssen
    • 13.2.6. Panacea
    • 13.2.7. Hualan Biological Engineering Inc.
    • 13.2.8. Serum Institute of India Ltd.
Back to Top